Pathophysiological aspects of frontotemporal dementia - Emphasis on cytoskeleton proteins and autoimmunity

Mechanisms of Ageing and Development

Volumn 122, Issue 16, 2001, Pages 1923-1935

  Sjögren, Magnus ^a   Wallin, Anders ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Cerebrospinal fluid; Frontotemporal dementia; Gangliosides; Neurofilament protein; Sulfatides; Tau

Indexed keywords

CYTOSKELETON PROTEIN; GANGLIOSIDE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN M ANTIBODY; NEUROFILAMENT PROTEIN; SULFATIDE; TAU PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; AUTOIMMUNITY; BLOOD ANALYSIS; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; FRONTOTEMPORAL DEMENTIA; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL;

AGED; AGED, 80 AND OVER; AUTOANTIBODIES; AUTOIMMUNITY; DEMENTIA; FEMALE; GANGLIOSIDES; HUMANS; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; NEUROFILAMENT PROTEINS; SULFOGLYCOSPHINGOLIPIDS; TAU PROTEINS;

EID: 0034810856     PISSN: 00476374     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0047-6374(01)00303-7     Document Type: Conference Paper

References (56)

1. Prevalence and incidence of clinically diagnosed memory impairments in a geographically defined general population in Sweden. The Pitea dementia project
2. Cerebrospinal fluid tau levels in neurodegenerative diseases with distinct tau-related pathology
3. The tau mutation (val337met) disrupts cytoskeletal networks of microtubuli
4. Protein analysis in cerebrospinal fluid: I. Influence of concentration gradients for proteins on cerebrospinal fluid/serum albumin ratio
5. Tau protein in cerebrospinal fluid: A biochemical marker for axonal degeneration in Alzheimer disease?
6. Inflammatory processes and antiinflammatory drugs in Alzheimer's disease: A current appraisal
7. The role of anti-inflammatory drugs in the prevention and treatment of Alzheimer's disease
8. Frontal lobe degeneration of non-Alzheimer type revisited
9. Clinical and neuropathological criteria for frontotemporal dementia
10. Inheritance of frontotemporal dementia
11. Alzheimer's disease cerebrospinal fluid antibodies display selectivity for microglia. Investigations with cell cultures and human cortical biopsies
12. Ballooned neurons in select neurodegenerative diseases contain phosphorylated neurofilament epitopes
13. 'Mini-mental State' A practical method for grading the cognitive state of patients for the clinician
14. Glycosphingolipids as potential diagnostic markers and/or antigens in neurological disorders
15. Increased tau in the cerebrospinal fluid of patients with frontotemporal dementia and Alzheimer's disease
16. Frontal lobe degeneration of non-Alzheimer type. II. Clinical picture and differential diagnosis
17. Clinical picture of frontal lobe degeneration of non-Alzheimer type
18. Hereditary frontotemporal dementia is linked to chromosome 17q21-q22: A genetic and clinicopathological study of three Dutch families
19. Frequency of tau mutations in three series of non-Alzheimer's degenerative dementia
20. The participation of interleukin-6, a stress-inducible cytokine, in the pathogenesis of Alzheimer's disease
21. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
22. Clinical and pathological overlap between frontotemporal dementia, Primary progressive aphasia and corticobasal degeneration: The Pick complex
23. Familial frontotemporal dementia with ubiquitin-positive, tau-negative inclusions
24. Dementia lacking distinctive histologic features: A common non-Alzheimer degenerative dementia
25. Regional and laminar synaptic pathology in frontal lobe degeneration of non-Alzheimer type
26. Ballooned neurons in several neurodegenerative diseases and stroke contain alpha B crystallin
27. The diseases of Alzheimer and Pick from the viewpoint of prevention
28. Immunohistochemical quantification of the synapse-related protein synaptophysin in Alzheimer disease
29. Stable expression in Chinese hamster ovary cells of mutated tau genes causing frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)
30. Tau protein in cerebrospinal fluid: A new diagnostic and prognostic marker in Alzheimer disease?
31. Tau and apo E in CSF: Potential aid for discriminating Alzheimer's disease from other dementias
32. Dementia of frontal lobe type
33. Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria
34. Inflammatory mechanisms in neurodegeneration and Alzheimer's disease: The role of the complement system
35. Familial progressive subcortical gliosis: Presence of prions and linkage to chromosome 17
36. Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein
37. High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the Netherlands
38. Neurofilament protein levels in CSF are increased in dementia
39. Semantic dementia with ubiquitin-positive tau-negative inclusion bodies
40. Search for a mutation in the tau gene in a Swiss family with frontotemporal dementia
41. Symptomatological characteristics distinguish between frontotemporal dementia and vascular dementia with a dominant frontal lobe syndrome
42. Cytoskeleton proteins in CSF distinguish frontotemporal dementia from AD
43. CSF levels of tau, B-amyloid42 and GAP-43 in frontotemporal dementia, other types of dementia and normal aging
44. Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein
45. Principles of albumin and IgG analysis in neurological disorders
46. Pick's disease
47. Aspartate residue 7 in amyloid beta-protein is critical for classical complement pathway activation: Implications for Alzheimer's disease pathogenesis
48. Demonstration of a specific profile of pathological tau proteins in frontotemporal dementia cases
49. Localization of the gene for rapidly progressive autosomal dominant parkinsonism and dementia with pallido-ponto-nigral degeneration to chromosome 17q21
50. Localization of disinhibition-dementia-Parkinsonism-amyotrophy complex to 17q21-22
51. Tau mutations in frontotemporal dementia
52. Frontotemporal dementia: Neuropil spheroids and presynaptic terminal degeneration